ARATANA THERAPEUTICS, INC. — Form D

ARATANA THERAPEUTICS, INC. of KANSAS CITY, KS, a company, filed a Form D exempt-offering notice with the SEC on 2011-01-07. The offering totals $20.0M, of which $10.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (25)

NameRoleLocation
Jay LichterExecutive OfficerLa Jolla, CA
David RosenExecutive OfficerNew York, NY
Jay LichterDirectorLa Jolla, CA
Jay Lichter, Ph.D.DirectorLa Jolla, CA
Jay Lichter, Ph.D.Executive OfficerLa Jolla, CA
Linda RhodesDirectorSan Francisco, CA
Linda RhodesExecutive OfficerSan Francisco, CA
Craig ToomanDirectorLondon, X0
Ron MeeusenDirectorEmeryville, CA
Robert GerberDirectorCARLSBAD, CA
Ernst A Heinen, D.V.M., Ph.D.Executive OfficerKansas City, KS
Steven L St. Peter, M.D.DirectorKansas City, KS
Steven L St. Peter, M.D.Executive OfficerKansas City, KS
Linda L Rhodes, V.M.D., Ph.D.DirectorKansas City, KS
Linda L Rhodes, V.M.D., Ph.D.Executive OfficerKansas City, KS
Ronald L Meeusen, Ph.D.DirectorBurr Ridge, IL
Louise A MawhinneyExecutive OfficerKansas City, KS
Craig L ToomanDirectorFar Hills, NJ
John L Vander VortDirectorBoston, MA
Julia A StephanusExecutive OfficerKansas City, KS
John Vander VortDirectorKansas City, KS
Steven St. PeterDirectorKansas City, KS
Steven St. PeterExecutive OfficerKansas City, KS
Ronald L. MeeusenDirectorKansas City, KS
Rip GerberDirectorKansas City, KS

Other filings by this issuer (3)

FiledFormOfferingSold
2013-10-23D$29.8M$29.8M
2012-12-28D$12.0M
2011-10-25D$15.5M

More